论文信息 - Initial Phase 3 Results Of The First (Frontline Investigation Of Lenalidomide + Dexamethasone Versus Standard Thalidomide) Trial (MM-020/IFM 07 01) In Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible For Stem Cell Transplantation (SCT) - 字舞流文

Initial Phase 3 Results Of The First (Frontline Investigation Of Lenalidomide + Dexamethasone Versus Standard Thalidomide) Trial (MM-020/IFM 07 01) In Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible For Stem Cell Transplantation (SCT)

M. Dimopoulos | J. Cavenagh | A. Dispenzieri | A. Belch | A. Oriol | P. Moreau | Je-Jung Lee | H. Ludwig | M. Delforge | T. Facon | M. Attal | L. Qiu | D. White | M. Cavo | Christine I. Chen | M. Tiab | L. Benboubker | C. Hulin | K. Weisel | J. Catalano | N. Bahlis | A. Banos | C. Geraldes | D. Binder | R. Knight | Guang Chen | C. Jacques | A. Ervin‐Haynes | Antonella Pinto | J. Rubia | K. Anderson | J. V. Oostendorp